RFP
ATYR

Root Financial Partners’s aTyr Pharma ATYR Stock Holding History

Root Financial Partners’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7 Buy
+9
New +$8 ﹤0.01% 3457

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Root Financial Partners's ATYR Position: Q1 2026 in Review

Root Financial Partners opened a new position in aTyr Pharma (ATYR) in Q1 2026: 9 shares worth $7. The stake represents ﹤0.01% of the portfolio and ranks #3457 among its holdings.

111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • Root Financial Partners held 9 shares of aTyr Pharma worth $7 as of Q1 2026.
  • aTyr Pharma was a new Root Financial Partners position in Q1 2026.
  • aTyr Pharma made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #3457 holding.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.